David, Marian
David, Marian was paid $8.28M by Medicaid between Jan 2018 and Dec 2024, across 48 billing codes. Its largest line is 93306, Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete — 21% of everything it billed.
33Billing provider infoDAVID, MARIAN
KEW GARDENS, NY 11415
KEW GARDENS, NY 11415
33aNPI1619073046assigned 09/15/2006
33bProvider typeSpecialist
28Total paid$8.28M
24GClaims130,152
24DCodes billed48
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in New York
Rank by total paid#16 of 1,221
Median peer was paid$45K
This provider vs. median183×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,325 | $1.59M | |
| 2019 | 30,326 | $2.13M | |
| 2020 | 25,883 | $1.68M | |
| 2021 | 13,616 | $647K | |
| 2022 | 12,355 | $599K | |
| 2023 | 14,567 | $807K | |
| 2024incomplete | 13,080 | $819K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 21% | 13,982 | 13,918 | $1.73M |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 17% | 7,782 | 7,762 | $1.38M |
| 93880 | 9.2% | 10,775 | 10,719 | $758K | |
| 93229 | 8.8% | 1,990 | 1,976 | $729K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.6% | 16,340 | 15,680 | $549K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 5.0% | 7,117 | 7,108 | $411K |
| 93015 | 3.7% | 7,850 | 7,836 | $310K | |
| 93922 | 2.8% | 4,491 | 4,471 | $233K | |
| 93351 | 2.8% | 1,341 | 1,339 | $231K | |
| 93970 | 2.6% | 2,562 | 2,550 | $214K | |
| 93924 | 2.0% | 1,700 | 1,698 | $163K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 1.9% | 2,921 | 2,865 | $154K |
36 more codes
| 93224 | 1.5% | 2,410 | $127K | |
| 95923 | 1.4% | 1,865 | $116K | |
| 94060 | 1.4% | 3,681 | $114K | |
| 93978 | 1.3% | 1,667 | $104K | |
| 93975 | 1.2% | 910 | $102K | |
| 93268 | 1.2% | 753 | $97K | |
| 94729 | 1.2% | 3,766 | $96K | |
| 93923 | 1.1% | 1,587 | $89K | |
| 94690 | <1% | 2,788 | $82K | |
| 93000 | <1% | 8,486 | $75K | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 3,844 | $73K |
| 93320 | <1% | 1,209 | $70K | |
| 93325 | <1% | 1,517 | $49K | |
| 95921 | <1% | 1,127 | $48K | |
| 94726 | <1% | 1,417 | $38K | |
| 94727 | <1% | 2,052 | $38K | |
| 93228 | <1% | 2,001 | $24K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 416 | $17K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 3,235 | $15K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 652 | $13K |
| 93976 | <1% | 118 | $7K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 463 | $5K |
| 95943 | <1% | 68 | $5K | |
| J1245 | Injection, dipyridamole, per 10 mg | <1% | 2,918 | $2K |
| 93308 | <1% | 40 | $2K | |
| 93979 | <1% | 41 | $1K | |
| 93458 | <1% | 12 | $1K | |
| 99442 | <1% | 58 | $905.61 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,561 | $878.46 |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 402 | $800.33 |
| 93321 | <1% | 70 | $707.15 | |
| 93971 | <1% | 20 | $508.08 | |
| 99305 | <1% | 34 | $421.14 | |
| 99304 | <1% | 13 | $368.85 | |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | <1% | 62 | $180.62 |
| 99152 | <1% | 38 | $157.49 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.